# Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA Levels

> **NCT04780204** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Asan Medical Center** · enrollment: 600 (estimated)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Treatment

## Key facts

- **NCT ID:** NCT04780204
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-23
- **Primary completion:** 2027-01
- **Final completion:** 2027-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04780204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04780204, "Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA Levels". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04780204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*